ABSTRACT. Glycopentalone isolated from Glycosmis pentaphylla (family Rutaceae) has cytotoxic and apoptosis inducing effects in various human cancer cell lines; however, its mode of action is not 2 A.B. gurung et al. Genetics and Molecular Research 15 (3): gmr.15038544 known. Therefore, target fishing of glycopentalone using a combined approach of inverse docking and reverse pharmacophore mapping approach was used to identify potential targets of glycopentalone, and gain insight into its binding modes against the selected molecular targets, viz., CDK-2, CDK-6, Topoisomerase I, Bcl-2, VEGFR-2, Telomere:Gquadruplex and Topoisomerase II. These targets were chosen based on their key roles in the progression of cancer via regulation of cell cycle and DNA replication. Molecular docking analysis revealed that glycopentalone displayed binding energies ranging from -6.38 to -8.35 kcal/mol and inhibition constants ranging from 0.758 to 20.90 µM. Further, the binding affinities of glycopentalone to the targets were in the order: Telomere:G-quadruplex > VEGFR-2 > CDK-6 > CDK-2 > Topoisomerase II > Topoisomerase I > Bcl-2. Binding mode analysis revealed critical hydrogen bonds as well as hydrophobic interactions with the targets. The targets were validated by reverse pharmacophore mapping of glycopentalone against a set of 2241 known human target proteins which revealed CDK-2 and VEGFR-2 as the most favorable targets. The glycopentalone was well mapped to CDK-2 and VEGFR-2 which involve six pharmacophore features (two hydrophobic centers and four hydrogen bond acceptors) and nine pharmacophore features (five hydrophobic, two hydrogen bond acceptors and two hydrogen bond donors), respectively. The present computational approach may aid in rational identification of targets for small molecules against large set of candidate macromolecules before bioassays validation.
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INTRODUCTION
The spread of abnormal cells and uncontrolled cell division, i.e., cancer, is a serious health issue worldwide (Greenlee et al., 2000; Gan et al., 2003; Siegel et al., 2015) . Chemotherapy, the use of cytotoxic compounds in the treatment of cancer and radiotherapy have traditionally been used to kill cancer cells, but both these methods in use have also led to serious side effects including anemia, asthenia, leukopenia, low immunity, nausea, and neutropenia (DeSantis et al., 2014) . Therefore, exploring natural products for effective drug lead for cancer is of great interest worldwide today. The discovery of a drug is a costly endeavor where a drug under experimentation has to be successfully passed through in-depth studies followed by clinical trials before it can be used as a treatment. In silico approaches such as molecular docking provide rapid ways to assess likely binding compounds with target macromolecules, and is therefore being widely practiced in pharmacology (Stark and Powers, 2012) . Inverse docking has proved to be an important computational tool in the identification of novel macromolecular targets for a drug or ligand pertaining to its mechanism of action and/ or side effects (Grinter et al., 2011; Chen and Ren, 2014) , and involves the docking of a small ligand or drug in potential binding sites of a set of clinically relevant macromolecular targets (Kharkar et al., 2014) . The second approach of target fishing is the reverse pharmacophore mapping approach, which is based on the fitting and mapping of small query molecules against predetermined pharmacophore features of targets (Liu et al., 2010) .
Glycosmis pentaphylla (Retz.) Correa (family Rutaceae), commonly known as 'orange berry' or 'gin berry', is used in the treatment of various ailments like anaemia, arthritis, cough, facial inflammation, jaundice and rheumatism (Mohammed et al., 2010) . G. pentaphylla has also previously been reported to have variety of biological activities such as antimicrobial (Abbas et al., 2011; Amran et al., 2011) ; antioxidant (Amran et al., 2011; Gupta et al., 2011) ; cytotoxic (Amran et al., 2011) ; hepatoprotective (Nayak et al., 2011) ; apoptotic (Sreejith et al., 2012; Yang et al., 2014) ; antiarthritic (Sivakumar et al., 2014) ; and anti-inflammatory activity (Prawej et al., 2015) . Recently, glycopentalone reported from G. pentaphylla has in vitro hepatocellular anticancer activity (Sreejith and Asha, 2015) ; however, the mode of action is unknown. Hence, in the present study, the molecular docking of glycopentalone with cyclin-dependent protein kinase, DNA topoisomerases, Bcl-2, VEGFR-2 and Telomere:Gquadruplex was performed in order to investigate binding interactions of glycopentalone with key enzymes and receptor proteins associated with cell division and DNA replication.
MATERIAL AND METHODS
The chemical structure of glycopentalone (Figure 1 ) was modeled using the software Chemsketch (http://www.acdlabs.com/resources/freeware/), and optimized by a MMFF94 force field using the optimization parameters (500 steepest descent algorithms, convergence criterion 10e-7; Halgren, 1996) . The optimized compound was used to perform molecular docking. The three dimensional structures of a total number of seven molecular targets (receptors) viz., CDK-2 (PDB ID:1DI8), CDK-6 (PDB ID:1XO2), Topoisomerase II (PDB ID:1ZXM), Topoisomerase I (PDB ID:1T8I), Bcl-2 (PDB ID:2O2F), VEGFR-2 (PDB ID:2OH4) and Telomere:G-quadruplex (PDB ID: 1L1H), were obtained from Protein Data Bank (PDB) (www.rcsb.org), and prepared for docking following a previously described method (Gurung et al., 2016) .
The inverse docking of glycopentalone was executed (parameters-initial population of randomly placed individuals: 150, maximum number of energy evaluations: 2,500,000, crossover rate: 0.8, mutation rate: 0.02, algorithm: lamarckian genetic, independent docking runs: 50) against receptors using AutoDock4.2 (Morris et al., 2009) . The conformations that differ by <2.0 Å RMSD (root mean square deviation) were clustered together. The most favorable conformation was represented by the lowest inhibition constant (Ki) and the lowest free energy of binding (∆G). The conformation with the lowest ∆G was evaluated for molecular interaction with their receptors using LigPlot+ v 1.4.5 (Laskowski and Swindells, 2011) . The parameters for hydrogen-bond calculations included a maximum hydrogen-acceptor distance of 2.70 Å and maximum donor-acceptor distance of 3.35 Å, while the non-bonded contact parameters included a minimum contact distance of 2.90 Å and a maximum contact distance of 3.90 Å. To ensure that the binding pose of the docked compound represents a favorable and valid potential binding mode, the docking parameters and methods were validated by redocking the cocrystal ligand in order to see the ability of the AutoDock program to reproduce the orientation and position of the ligand observed in the crystal structure. The figures for docking validation and binding site pockets were captured using UCSF chimera (Pettersen et al., 2004) .
Reverse pharmacophore database screening
The PharmMapper server (http://59.78.96.61/pharmmapper/) was used to validate the targets of glycopentalone based on the pharmacophore mapping approach (Liu et al., 2010) . It correctly identified some of the experimentally determined targets of Tamoxifen, used as an adjuvant therapy in the treatment of breast cancer (Hughes-Davies et al., 2009) , indicating the reliability of the server for target fishing. Pharmmapper contains 7302 pharmacophore models (2241 annotated as human target proteins) generated using the LigandScout software which extract 3D pharmacophore features such as hydrophobic centre, positive charged centre, negative charged centre, hydrogen bond acceptor, hydrogen bond donor and aromatic ring. There are two steps involved in the reverse pharmacophore mapping methodology employed in the Pharmmapper server: a) flexible alignment of queried small molecules against a pharmacophore model of each target; and b) scoring of aligned poses by calculating fit values between the molecule and the pharmacophore models. We used default parameters of the PharmMapper server, such as: a) conformation generation of query molecule based on the MOEA-based conformation generation algorithm Cyndi (Liu et al., 2009 ); b) target set chosen as human targets; and c) genetic algorithm was used to optimize pharmacophore mapped poses. The pharmacophore mapped features of glycopentalone were visualized using Discovery Studio 4.1 Visualizer.
RESULTS AND DISCUSSION

Inverse docking analysis
The redocking of cocrystal ligands to their respective molecular targets exhibited RMSD of < 2 Å between the original cocrystal ligand position and docked poses as shown in Figure 2 . This confirmed that the ligands were bound to their targets very close to the true conformation, indicating the reliability of the docking protocols and parameters. Glycopentalone was docked against seven molecular targets, viz., CDK-2, CDK-6, Topoisomerase I, Bcl-2, VEGFR-2, Telomere:G-quadruplex and Topoisomerase II, to gain insight into their possible binding modes. The active site residue(s), grid box dimensions, binding energies, and inhibition constants of glycopentalone against the selected targets are shown in Tables 1 and 2 Table 2 . Binding energies and inhibition constants of glycopentalone docked against molecular targets.
Compounds Drug targets (PDB Entries)
CDK-2(1DI8) Glycopentalone was docked to CDK-2 and CDK-6 with binding energies of -7.56 and -7.99 kcal/mol and inhibition constants of 2.87 and 1.39 µM, respectively. Both CDK-2 and CDK-6 belong to core-cell cycle machinery and exert their catalytic functions when bound to cyclins. They play crucial roles in cell cycle regulation, apoptosis, transcription, and neuronal functions (Dai and Grant, 2003; Huwe et al., 2003) . The favorable binding interaction of glycopentalone with CDK-2 may be attributed to the formation of three hydrogen bonds with bond lengths of 2.76, 2.81, and 2.61 Å via backbone O atoms of Glu81 and Leu83 and N atom of Leu83, respectively, and hydrophobic interactions were mediated through Ile10, Val18, Ala31, Val64, Phe80, Phe82, His84, Gln85, Leu134, and Ala144. Interestingly, all the hydrogen bonds were found to be established through only backbone O and N atoms of the contributing residues. Similarly, glycopentalone showed good interaction with CDK-6. This interaction comprises of five hydrogen bonds with hydrogen-acceptor distances of 2.54, 3.05, 3.04, 2.94, and 3.09 Å through backbone a O atom of Glu99, side chain NE2 atom of His100, backbone N and O atom of Val101, and backbone N atom of Asp163, respectively, and hydrophobic interactions via Ile19, Ala41, Lys43, Val77, Phe98, Asp102, Gln103, Leu152, and Ala162.
Glycopentalone showed a binding energy of -6.78 kcal/mol and an inhibition constant of 10.69 µM with Topoisomerase I and with Topoisomerase II it displayed a binding energy of -6.99 kcal/mol and an inhibition constant of 7.50 µM. Both DNA Topoisomerases I and II have implicated functions in cell survival and play critical roles in DNA metabolism and structure (Phosrithong and Ungwitayatorn, 2010) . Glycopentalone showed fine interaction with Topoisomerase I, which involved five hydrogen bonds of distances 3.30, 2.97, 2.40, 2.98, and 3.05Å formed via backbone N atom and O atom of Asn352, backbone O atom of Tyr426, backbone N atom of Met428 and side chain NZ atom of Lys436 respectively, and hydrophobic interactions via Ala351, Ala356 and Ile. Glycopentalone also displayed good interaction with Topoisomerase II through the establishment of three hydrogen bonds with hydrogen-acceptor distances via side chain ND2 atom of Asn9, side chain ND2 atom of Asn150 and backbone N atom of Ala167, and hydrophobic interactions via Phe142, Ser148, Ser149, Gly161, Arg162, and Gly164.
Glycopentalone exhibited a binding energy of -6.38 kcal/mol and inhibition constant of 20.90 µM with Bcl-2. Bcl-2 is an anti-apoptotic oncoprotein, which affects neoplastic cell proliferation by preventing cell death (Reed, 1994) . However, glycopentalone did not show a favorable interaction with Bcl-2, which may be understood by the fact that it was able to establish just one hydrogen bond of distance 2.67 Å with backbone O atom of Val130, while a major interaction was contributed by hydrophobic interactions through Phe101, Tyr105, Asp108, Phe109, Leu134, Ala146, Phe147, and Phe150.
Glycopentalone docked to VEGFR-2 with a binding energy of -8.14 kcal/mol and inhibition constant of 1.08 µM. VEGFR-2 is a cell surface receptor for VEGF, expressed highly on vascular endothelial cells and can modulate vascular endothelial survival, proliferation, migration and the formation of vascular tubes (Veikkola et al., 2000) . Glycopentalone was able to establish three hydrogen bonds of distances measuring 2.64, 3.32, and 3.16 Å via side chain OE2 atom of Glu883, backbone O atom of Ile1042 and backbone O atom of Phe1045 respectively, and hydrophobic interactions via Val846, Lys866, Leu887, Val897, Val914, His1024, Leu1033, Cys1043, and Asp1044.
Glycopentalone exhibited a decent binding energy of -8.35 kcal/mol and inhibition constant of 0.758 µM with Telomere G:quadruplex. Telomeres are highly complex nucleoprotein structures at the end of eukaryotic chromosomes, which influence the proliferative capacity of cells. The mammalian telomeric DNA is composed of G-rich tandem repeats (TTAGGG) n . The bulk of telomeric DNA is double-stranded but the extreme terminus consists of 3'G-rich single stranded overhang of several hundred bases that act as substrate to which telomeric repeats are added by the enzyme telomerase (Henderson and Blackburn, 1989; Satyanarayana et al., 2004) . Glycopentalone was able to establish two hydrogen bonds of distances 2.77 and 2.87 Å via O2 atoms of a pyrimidine ring of Dg1006 and O5' atom of phosphate backbone of Dg1009, respectively, and hydrophobic interactions via Dg1007, Dg1008, Dg2001, and Dg2012.
Reverse pharmacophore mapping analysis
The reverse pharmacophore mapping approach was used to validate the possible targets of glycopentalone suggested by the inverse docking method. Recently, Lei et al. (2015) reported possible targets of 26 isoquinoline alkaloids from Macleaya cordata using the reverse pharmacophore mapping approach, which correlated with their experimentally determined antibacterial, antiparasitic, antitumor, and analgesic effects. We mapped pharmacophore features of glycopentalone against a set of 2241 human target proteins. Of 300 targets identified through Pharmmapper server, we present the top 30 ranked targets for glycopentalone in Table 3 . Consistent with our molecular docking results, CDK-2 and VEGFR-2 ranked among the top 30 targets. Glycopentalone aligned with the pharmacophore model of CDK-2 (Rank 8) with a fit score of 3.785, Z'score of 2.96152 and displayed six pharmacophore features comprising of two hydrophobic centres and four hydrogen bond acceptor ( Figure  4A) . Similarly, glycopentalone aligned with the pharmacophore model of VEGFR-2 (Rank 20) with a Fit Score of 3.71, Z'score of 1.57072 and displayed nine pharmacophore features comprising of five hydrophobic, two hydrogen bond acceptor and two hydrogen bond donors ( Figure 4B ). Both the models are statistically significant indicated by large positive Z'-score. Thus, the combined approach of inverse docking and reverse pharmacophore mapping analysis indicates that CDK-2 and VEGFR-2 are the most favorable target for glycopentalone. 
CONCLUSIONS
The inverse docking analysis of glycopentalone with macromolecules involved in the cell cycle and DNA replication revealed good interactions with Telomere:G-quadruple, VEGFR-2, CDK-6, CDK-2, Topoisomerase II, and Topoisomerase I. We found that glycopentalone's binding energies and inhibition constants were much higher than the bound cocrystal ligands against each molecular target. Glycopentalone showed binding affinities in the descending order as Telomere:G-quadruplex > VEGFR-2 > CDK-6 > CDK-2 > Topoisomerase II > Topoisomerase I > Bcl-2. Glycopentalone displayed binding energies ranging from -6.38 to -8.35 kcal/mol and inhibition constants ranging from 0.758 to 20.90 µM, and exhibited favorable number of hydrogen bonds and hydrophobic interactions with the molecular targets, which indicates its good binding affinity towards the selected molecular targets. The inverse docking suggested targets were validated by a reverse pharmacophore mapping approach, which ranked CDK-2 and VEGFR-2 among the top 30 candidates of 300 possible targets. We found CDK-2 and VEGFR-2 as the most favorable targets of glycopentalone using both approaches, which perhaps gives a reasonable explanation for its experimentally determined cytotoxic and apoptosis promoting effects. Since glycopentalone did not exhibit decent binding energies compared to that of cocrystal ligands, a structure-activity relationship study may be useful in this regard to derive more potent target specific inhibitors. The inverse docking coupled with reverse pharmacophore mapping approach may be of great significance in target fishing of newly discovered small molecules such as natural bioactive compounds.
Conflicts of interest
The authors declare no conflict of interest.
